- Home
- KIDS vs GRAL Comparison
KIDS vs GRAL Comparison
Compare KIDS & GRAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIDS
- GRAL
- Stock Information
- Founded
- KIDS 2007
- GRAL 2016
- Country
- KIDS United States
- GRAL United States
- Employees
- KIDS N/A
- GRAL N/A
- Industry
- KIDS Medical/Dental Instruments
- GRAL
- Sector
- KIDS Health Care
- GRAL
- Exchange
- KIDS Nasdaq
- GRAL NYSE
- Market Cap
- KIDS 530.8M
- GRAL 1.3B
- IPO Year
- KIDS 2017
- GRAL N/A
- Fundamental
- Price
- KIDS $22.48
- GRAL $46.87
- Analyst Decision
- KIDS Buy
- GRAL Buy
- Analyst Count
- KIDS 7
- GRAL 3
- Target Price
- KIDS $35.71
- GRAL $31.50
- AVG Volume (30 Days)
- KIDS 137.2K
- GRAL 1.6M
- Earning Date
- KIDS 08-04-2025
- GRAL 08-12-2025
- Dividend Yield
- KIDS N/A
- GRAL N/A
- EPS Growth
- KIDS N/A
- GRAL N/A
- EPS
- KIDS N/A
- GRAL N/A
- Revenue
- KIDS $212,453,000.00
- GRAL $130,711,000.00
- Revenue This Year
- KIDS $19.23
- GRAL $19.52
- Revenue Next Year
- KIDS $17.14
- GRAL $20.37
- P/E Ratio
- KIDS N/A
- GRAL N/A
- Revenue Growth
- KIDS 31.28
- GRAL 30.47
- 52 Week Low
- KIDS $19.52
- GRAL $12.33
- 52 Week High
- KIDS $35.99
- GRAL $63.99
- Technical
- Relative Strength Index (RSI)
- KIDS 61.04
- GRAL N/A
- Support Level
- KIDS $21.00
- GRAL N/A
- Resistance Level
- KIDS $21.83
- GRAL N/A
- Average True Range (ATR)
- KIDS 0.74
- GRAL 0.00
- MACD
- KIDS 0.19
- GRAL 0.00
- Stochastic Oscillator
- KIDS 97.94
- GRAL 0.00
About KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
About GRAL GRAIL INC
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.